Aug 06,2019

BD Announces Results For 2019 Third Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $4.350 billion for the third fiscal quarter ended June 30, 2019. This represents an increase of 1.7 percent over the prior-year period. On a comparable, currency-neutral basis, revenues increased 5.7 percent over the prior-year period.

View Analyst & Ambassador Comments
Go to original news
Aug 07,2019

Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced the first shipments of SugarBEAT® to diabetic and pre-diabetic patients in the United Kingdom. These shipments are part of the first phase of Nemaura Medical’s rollout program for SugarBEAT® following its recent CE mark approval in Europe.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 07,2019

DarioHealth to Host Second Quarter 2019 Conference Call August 13, 2019

Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its second quarter 2019 results on Tuesday, August 13, and host a conference call the same morning at 9:00 am EDT.

View Analyst & Ambassador Comments
Go to original news
Aug 09,2019

Insulet Omnipod DASH™ System Mobile Apps Now Available for iOS Devices

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the full market launch of the Company’s Omnipod DISPLAY™ and Omnipod VIEW™ apps for those using the new Omnipod DASH™ System. The apps are now available to download from the iOS App Store.

PRODUCT

#insulin pump

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 09,2019

Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019

Nemaura Medical, Inc., a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today reported financial results for the first quarter ended June 30, 2019.

View Analyst & Ambassador Comments
Go to original news
Aug 12,2019

DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements

DarioHealth Corp., a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators ("AADE") conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario's digital therapeutics platform and dedicated one-on-one personal health coaching.

CLINICAL STUDY

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 13,2019

DarioHealth Reports Results For Second Quarter 2019

Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018. Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018. Expense shift from D2C to B2B, resulting in a short-term decline in Revenue and an expectation of significant reductions to Net loss in 2H 2019.

View Analyst & Ambassador Comments
Go to original news
Aug 14,2019

Medtronic Partners With Capital District Physicians’ Health Plan, Inc. (CDPHP) on Outcomes-based Agreement to Increase Quality and Improve Access to Critical Diabetes Care

Medtronic plc, the global leader in medical technology, and Capital District Physicians' Health Plan, Inc. (CDPHP) today announced an innovative outcomes-based agreement for individuals with type 1 and type 2 diabetes that utilize a Medtronic insulin pump. Under the strategic partnership, Medtronic will provide eligible CDPHP members access to state-of-the-art technologies, supplies, and education and training support services to manage their diabetes. Additionally, a component of Medtronic's reimbursement will be tied to successfully meeting agreed upon clinical improvement thresholds for enrolled members – such as A1C reduction, increased Time in Range, and reduced hypoglycemic events.

COLLABORATION PARTNERSHIP

#insurance

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Aug 15,2019

DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

Dario was selected by DH.L to help bring its highly regarded digital therapeutics technology to assist NHS patients in better managing their chronic health conditions, such as pre-diabetes, diabetes and hypertension, among other chronic conditions. The Initiative is a partnership between the UK Israel Tech Hub, which aims to help British companies partner with cutting-edge technology companies in Israel; DigitalHealth.London, a collaborative that helps high-potential, digital health start-up companies connect with the NHS; and Dangoor Education.

COLLABORATION PARTNERSHIP

#institution

#dtx

View Analyst & Ambassador Comments
Go to original news
Aug 16,2019

Medtronic Approved to Start Pivotal Trial to Evaluate New Extended Wear Infusion Set

Medtronic plc, the global leader in medical technology, today announced that it received investigational approval from the U.S. Food and Drug Administration (FDA) to proceed with a pivotal trial for a new extended wear infusion set. The goal of the study will be to collect clinical data to support the use of the extended wear infusion set for up to seven days – more than twice the length of time that any infusion set can currently be used. The multi-center, non-randomized, prospective single arm study will enroll up to 150 subjects, aged 18 to 80, with type 1 diabetes on insulin pump therapy.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES